DiaMedica Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing treatment for ischemic diseases with two main clinical programs focused on acute ischemic stroke (AIS) and preeclampsia (PE). Its main product candidate DM199 (rinvecalinase alfa) is a recombinant form of human tissue kallikrein-1, which is a synthetic version of the naturally occurring protease enzyme kallikrein-1 and a rhKLK1 undergoing clinical development studies in both AIS and PE. The other product candidate in the company's pipeline is DM300, its patented recombinant human ulinastatin, a broad-spectrum serine protease inhibitor, being developed as a potential therapy for severe acute pancreatitis.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy DiaMedica Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for DiaMedica Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for DiaMedica Therapeutics Inc. is DMAC:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
DiaMedica Therapeutics Inc. has its primary listing on NASDAQ (Small cap). You can trade DiaMedica Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, DiaMedica Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include DiaMedica Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like DiaMedica Therapeutics Inc..